Skip to main content

Qiming Venture Partners — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

399
Companies
$14.9B
Total invested
$60.5M
Avg. check
37
Industries
Biotechnology 11Medical 8Artificial Intelligence (AI) 7Health Care 6Therapeutics 6Software 4+31 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121–144 of 399
AusperBio
September 2025

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

Biopharma · Foster City$63.0M Series B
Agloe Medical
September 2025

Agloe Medical is a company offering research, development, and sales of Class II and Class III medical devices and electronic components.

Manufacturing · Suzhou$15.5M Series A
Fasikl
September 2025

Fasikl is a neuro-AI company that creates interfaces for the nervous system.

Artificial Intelligence (AI) · Bloomington$26.6M Series B
Dualitas Therapeutics
September 2025

Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders

Biotechnology · San Francisco$65.0M Series A
Epigenic Therapeutics
September 2025

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Biotechnology · Shanghai$60.0M Series B
GenEditBio
August 2025

GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.

Biotechnology · BeijingSeries Unknown
Mech-Mind Robotics
August 2025

Mech-Mind is a global leading provider of industrial 3D sensors and AI-powered software for intelligent robots.

Artificial Intelligence (AI) · Beijing$69.9M Series D
Sany Hydrogen Energy
August 2025

Sany Hydrogen Energy focuses on R&D, manufacturing, and solutions for water electrolysis hydrogen production.

Electronics · Huanghua$23.8M Series A
Huimei Technology
August 2025

Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.

Artificial Intelligence (AI) · Haidian$27.8M Series Unknown
CANbridge Pharmaceuticals
August 2025

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

Biotechnology · Beijing$12.7M Post Ipo Equity
WAM Bio
August 2025

WAM Bio is a company operating in stealth mode.

Dover$1.5M Seed
Minghui Pharmaceutical
August 2025

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Biopharma · Shanghai$131.0M Series Unknown
Tongxuan Medical
August 2025

Tongxuan Medical is a platform for balloon interventional device research and development.

Health Care · Cheng$41.8M Series B
LTZ Therapeutics
July 2025

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

Biotechnology · San FranciscoCorporate Round
Atantares
July 2025

Atantares is a company that makes smart chips that empower medical technology.

Health Diagnostics · Jingan$8.6M Series A
Simaixu Biotechnology
July 2025

Simaixu Biotechnology is a biopharmaceutical firm that develop small molecule drugs for cancer, and chronic diseases with new technologies

Biotechnology · Suzhou$1.6M Series Unknown
Sharpa
July 2025

Sharpa is a robotics company that develops robots and core robotic components for real-world deployment of robotic applications.

Artificial Intelligence (AI) · Singapore$100.0M Series A
Auron Therapeutics
July 2025

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

Biotechnology · NewtonSeries Unknown
TigerGraph
July 2025

TigerGraph supports advanced analytics and machine learning platforms through its distributed native graph database.

Analytics · Redwood CitySeries Unknown
Renasant Bio
July 2025

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Biotechnology · Berkeley$54.5M Seed
TARS
July 2025

TARS is a company that integrates embodied intelligence.

Artificial Intelligence (AI) · Xuhui$122.0M Seed
Sesame Therapeutics
July 2025

Sesame Therapeutics is a healthcare company that provides precision oncology medicines with therapeutic windows.

Medical · Plymouth$19.0M Series A
Z.ai
July 2025

Z.ai is an AI company that develops foundational AI models and tools that support language, voice, and multimedia tasks.

Artificial Intelligence (AI) · Haidian$139.6M Private Equity
Biren Technology
June 2025

Biren Technology is an AI chip startup that develops intelligent processors for GPU and DSA computation architectures.

AI Infrastructure · Minhang$209.3M Series Unknown

Where Qiming Venture Partners invests

Biotechnology11
Medical8
Artificial Intelligence (AI)7
Health Care6
Therapeutics6
Software4

About Qiming Venture Partners's portfolio

How many companies has Qiming Venture Partners invested in?▸

Qiming Venture Partners has invested in 399 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Qiming Venture Partners invest in?▸

Qiming Venture Partners's top investment sectors include Biotechnology, Medical, Artificial Intelligence (AI), Health Care, Therapeutics. The firm invests across 37 different industry categories.

What is Qiming Venture Partners's largest investment?▸

Among tracked funding rounds, Biren Technology received $209.3M in a Series Unknown round. Qiming Venture Partners's total known invested capital is $14.9B.

What is the average investment size for Qiming Venture Partners?▸

Qiming Venture Partners's average investment size is $60.5M across its portfolio of 399 companies.

What are Qiming Venture Partners's most recent investments?▸

Recent Qiming Venture Partners portfolio additions include AusperBio, Agloe Medical, Fasikl, Dualitas Therapeutics, Epigenic Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 399 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →